Seller record · Research vendor

Swiss Chems

By Peptide Alliance, Editorial publisherRecorded August 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician appears anywhere on the site. Sales involve no prescriber. 2 more criteria also fail; see the table below.

At a glance

Swiss ChemsResearch vendor

4/8criteria passed
Price
Printed on its own pages before sign-up
Sells
BPC-157, TB-500, KPV, and 7 more
FDA letters
1 on file
Visit Swiss ChemsSee all eight dispositions

Research vendor. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A research-chemical vendor selling peptides and SARMs with open carts and third-party test reports. An FDA warning letter names it.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementFAILSwiss Chems' website
S2Prescription gatingFAILSwiss Chems' term conditions
S3Pharmacy identificationFAILSwiss Chems' website
S4Compounding disclosurePASSSwiss Chems' term conditions
S5Analytical documentationPASSSwiss Chems' posted image
S6Business addressNOT VERIFIEDSwiss Chems' contact page
S7Price disclosurePASSSwiss Chems' website
S8Enforcement statusPASSFDA's website; FDA warning letter 695663

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date. A row that was re-checked later states its own date.

S1FAILNo clinician appears anywhere on the site. Sales involve no prescriber.Source: Swiss Chems' website.
S2FAILProducts add to cart directly. The only gate is an age attestation.Source: Swiss Chems' term conditions.
S3FAILNo pharmacy involvement is claimed anywhere on the site.Source: Swiss Chems' website.
S4PASSSells no compounded drugs; every page states research use only, not for human consumption.Source: Swiss Chems' term conditions.
S5PASSThe test results page shows reports from Freedom Diagnostics, among them tesamorelin lot 2607-ED-TE, issued to a client named IMT rather than to Swiss Chems.Source: Swiss Chems' posted image · read September 2026.
S6NOT VERIFIEDNo street address appeared on the pages read, and a request for the contact page did not resolve, which returned an access block. The check is open.Source: Swiss Chems' contact page.
S7PASSPrices are printed on every product page, with no account or intake required.Source: Swiss Chems' website.
S8PASSFDA warning letter 695663, December 2024, names Swisschems over unapproved semaglutide and retatrutide offered from this domain. No close-out letter appears in the index. No FDA action has halted the business, and the store still trades.Source: FDA's website; FDA warning letter 695663.

Products shown on the seller's own pages at the recorded date: BPC-157, TB-500, KPV, Semax, Epitalon, DSIP, MOTS-c, NAD+, sermorelin, SARMs.

Other sellers of the same products

Who sells sermorelinWho sells NAD+Who sells BPC-157Who sells TB-500Who sells MOTS-cWho sells semaxWho sells epitalon

Enforcement documents on file: 1 warning letter

FDA warning letter 695663, issued December 2024, to SwisschemsThe semaglutide and retatrutide products offered from Swiss Chems' website are unapproved new drugs intended for human use, despite research-chemical labeling.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Swiss Chems

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.